Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• CAMPATH-1 antibodies are highly effective in depleting human lymphocytes via complement-mediated lysis.
• These antibodies target a unique glycosylphosphatidylinositol (GPI)-anchored glycoprotein expressed on lymphocytes.
• Previous applications include lymphocyte depletion in various clinical conditions.

Purpose of the Study:

• To elucidate the structural and functional characteristics of the CAMPATH-1 antigen.
• To identify the specific epitope recognized by CAMPATH-1 antibodies.
• To understand the molecular basis for the antigen's efficacy as a target for cell lysis.

Main Methods:

• Characterization of the CAMPATH-1 antigen's structure, including peptide and glycosylation.
• Analysis of the antigenic epitope through proteolytic fragmentation.
• Functional assays involving re-incorporation of antigen fragments into target cells.

Main Results:

• The CAMPATH-1 antigen is a small GPI-anchored glycoprotein with a 12-amino acid mature peptide and one N-linked glycosylation site.
• The epitope is located within a proteolytic fragment containing the C-terminal tripeptide and the GPI anchor.
• Re-incorporation of native, deglycosylated antigen, or the fragment into cells conferred sensitivity to CAMPATH-1 mediated lysis.

Conclusions:

• The N-linked sugar and the initial amino acids are not critical for CAMPATH-1 antibody recognition.
• The proximity of the antigenic epitope to the cell membrane is a key factor for effective targeting.
• These findings support the hypothesis that membrane proximity enhances the antigen's utility for lymphocyte depletion therapies.